APO Research
Talk to an analyst

APO RESEARCH · REPORT

Demerol (Meperidine)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Demerol (Meperidine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchDemerol (Meperidine) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Demerol (Meperidine) Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Demerol (Meperidine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Demerol (Meperidine) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Demerol (Meperidine) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Demerol (Meperidine) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Demerol (Meperidine) include Sun Pharmaceuticals, Sanofi, Pfizer, Purdue Pharma, Mallinckrodt Pharmaceuticals, Janssen, Endo Pharmaceuticals, Egalet and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Demerol (Meperidine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Demerol (Meperidine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Demerol (Meperidine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Demerol (Meperidine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Demerol (Meperidine) Segment by Company

Sun Pharmaceuticals

Sanofi

Pfizer

Purdue Pharma

Mallinckrodt Pharmaceuticals

Janssen

Endo Pharmaceuticals

Egalet

Boehringer Ingelheim

Actavis

Demerol (Meperidine) Segment by Type

Powder

Liquid

Demerol (Meperidine) Segment by Application

Diarrhea Treatment

Cough Treatment

Anesthesia

Demerol (Meperidine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Demerol (Meperidine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Demerol (Meperidine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Demerol (Meperidine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Demerol (Meperidine) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Demerol (Meperidine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Demerol (Meperidine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Demerol (Meperidine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Demerol (Meperidine) Industry Trends Table 2. Demerol (Meperidine) Industry Drivers Table 3. Demerol (Meperidine) Industry Opportunities and Challenges Table 4. Demerol (Meperidine) Industry Restraints Table 5. Global Demerol (Meperidine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Demerol (Meperidine) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Demerol (Meperidine) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Demerol (Meperidine) Sales Market Share by Manufacturers Table 9. Global Demerol (Meperidine) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Demerol (Meperidine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Demerol (Meperidine) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Demerol (Meperidine) Manufacturers, Product Type & Application Table 13. Global Demerol (Meperidine) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Demerol (Meperidine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Liquid Table 18. Global Demerol (Meperidine) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 20. Global Demerol (Meperidine) Sales by Type (2027-2032) & (K Units) Table 21. Global Demerol (Meperidine) Sales Market Share by Type (2021-2026) Table 22. Global Demerol (Meperidine) Sales Market Share by Type (2027-2032) Table 23. Global Demerol (Meperidine) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Demerol (Meperidine) Revenue by Type (2021-2026) & (K Units) Table 25. Global Demerol (Meperidine) Revenue by Type (2027-2032) & (K Units) Table 26. Global Demerol (Meperidine) Revenue Market Share by Type (2021-2026) Table 27. Global Demerol (Meperidine) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Diarrhea Treatment Table 29. Major Manufacturers of Cough Treatment Table 30. Major Manufacturers of Anesthesia Table 31. Global Demerol (Meperidine) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 33. Global Demerol (Meperidine) Sales by Application (2027-2032) & (K Units) Table 34. Global Demerol (Meperidine) Sales Market Share by Application (2021-2026) Table 35. Global Demerol (Meperidine) Sales Market Share by Application (2027-2032) Table 36. Global Demerol (Meperidine) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Demerol (Meperidine) Revenue by Application (2021-2026) & (K Units) Table 38. Global Demerol (Meperidine) Revenue by Application (2027-2032) & (K Units) Table 39. Global Demerol (Meperidine) Revenue Market Share by Application (2021-2026) Table 40. Global Demerol (Meperidine) Revenue Market Share by Application (2027-2032) Table 41. Global Demerol (Meperidine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Demerol (Meperidine) Sales by Region (2021-2026) & (K Units) Table 43. Global Demerol (Meperidine) Sales Market Share by Region (2021-2026) Table 44. Global Demerol (Meperidine) Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Demerol (Meperidine) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 48. North America Demerol (Meperidine) Sales by Country (2027-2032) & (K Units) Table 49. Europe Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 51. Europe Demerol (Meperidine) Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Demerol (Meperidine) Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Demerol (Meperidine) Sales by Country (2027-2032) & (K Units) Table 58. Global Demerol (Meperidine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Demerol (Meperidine) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Demerol (Meperidine) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Demerol (Meperidine) Revenue Market Share by Region (2021-2026) Table 62. Global Demerol (Meperidine) Revenue Market Share by Region (2027-2032) Table 63. Sun Pharmaceuticals Company Information Table 64. Sun Pharmaceuticals Business Overview Table 65. Sun Pharmaceuticals Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sun Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 67. Sun Pharmaceuticals Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Demerol (Meperidine) Product Portfolio Table 72. Sanofi Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Demerol (Meperidine) Product Portfolio Table 77. Pfizer Recent Development Table 78. Purdue Pharma Company Information Table 79. Purdue Pharma Business Overview Table 80. Purdue Pharma Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Purdue Pharma Demerol (Meperidine) Product Portfolio Table 82. Purdue Pharma Recent Development Table 83. Mallinckrodt Pharmaceuticals Company Information Table 84. Mallinckrodt Pharmaceuticals Business Overview Table 85. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 87. Mallinckrodt Pharmaceuticals Recent Development Table 88. Janssen Company Information Table 89. Janssen Business Overview Table 90. Janssen Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Janssen Demerol (Meperidine) Product Portfolio Table 92. Janssen Recent Development Table 93. Endo Pharmaceuticals Company Information Table 94. Endo Pharmaceuticals Business Overview Table 95. Endo Pharmaceuticals Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Endo Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 97. Endo Pharmaceuticals Recent Development Table 98. Egalet Company Information Table 99. Egalet Business Overview Table 100. Egalet Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Egalet Demerol (Meperidine) Product Portfolio Table 102. Egalet Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Demerol (Meperidine) Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Actavis Company Information Table 109. Actavis Business Overview Table 110. Actavis Demerol (Meperidine) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Actavis Demerol (Meperidine) Product Portfolio Table 112. Actavis Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Demerol (Meperidine) Distributors List Table 116. Demerol (Meperidine) Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Demerol (Meperidine) Product Image Figure 2. Global Demerol (Meperidine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Demerol (Meperidine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Demerol (Meperidine) Sales (2021-2032) & (K Units) Figure 5. Global Demerol (Meperidine) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Demerol (Meperidine) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Liquid Image Figure 10. Global Demerol (Meperidine) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Demerol (Meperidine) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Demerol (Meperidine) Sales Market Share by Type (2021-2032) Figure 13. Global Demerol (Meperidine) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Demerol (Meperidine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Demerol (Meperidine) Revenue Market Share by Type (2021-2032) Figure 16. Diarrhea Treatment Image Figure 17. Cough Treatment Image Figure 18. Anesthesia Image Figure 19. Global Demerol (Meperidine) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Demerol (Meperidine) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Demerol (Meperidine) Sales Market Share by Application (2021-2032) Figure 22. Global Demerol (Meperidine) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Demerol (Meperidine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Demerol (Meperidine) Revenue Market Share by Application (2021-2032) Figure 25. North America Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Demerol (Meperidine) Sales Market Share by Country (2021-2032) Figure 27. U.S. Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Demerol (Meperidine) Sales Market Share by Country (2021-2032) Figure 32. Germany Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Demerol (Meperidine) Sales Market Share by Country (2021-2032) Figure 39. China Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Demerol (Meperidine) Sales Market Share by Country (2021-2032) Figure 47. Brazil Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Demerol (Meperidine) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Demerol (Meperidine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Demerol (Meperidine) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Demerol (Meperidine) Revenue (2021-2032) & (US$ Million) Figure 58. North America Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Demerol (Meperidine) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Demerol (Meperidine) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Demerol (Meperidine) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Demerol (Meperidine) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Demerol (Meperidine) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Diarrhea Treatment
  • Cough Treatment
  • Anesthesia
Companies covered
  • Sun Pharmaceuticals
  • Sanofi
  • Pfizer
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Janssen
  • Endo Pharmaceuticals
  • Egalet
  • Boehringer Ingelheim
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Demerol (Meperidine) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Demerol (Meperidine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Demerol (Meperidine) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Demerol (Meperidine) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Demerol (Meperidine) Market Dynamics
  1. 2.1 Demerol (Meperidine) Industry Trends
  2. 2.2 Demerol (Meperidine) Industry Drivers
  3. 2.3 Demerol (Meperidine) Industry Opportunities and Challenges
  4. 2.4 Demerol (Meperidine) Industry Restraints
3 Demerol (Meperidine) Market by Manufacturers
  1. 3.1 Global Demerol (Meperidine) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Demerol (Meperidine) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Demerol (Meperidine) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Demerol (Meperidine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Demerol (Meperidine) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Demerol (Meperidine) Manufacturers, Product Type & Application
  7. 3.7 Global Demerol (Meperidine) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Demerol (Meperidine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Demerol (Meperidine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Demerol (Meperidine) Tier 1, Tier 2, and Tier 3
4 Demerol (Meperidine) Market by Type
  1. 4.1 Demerol (Meperidine) Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Demerol (Meperidine) Sales by Type
  5. 4.2.1 Global Demerol (Meperidine) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Demerol (Meperidine) Sales by Type (2021-2032)
  7. 4.2.3 Global Demerol (Meperidine) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Demerol (Meperidine) Revenue by Type
  9. 4.3.1 Global Demerol (Meperidine) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Demerol (Meperidine) Revenue by Type (2021-2032)
  11. 4.3.3 Global Demerol (Meperidine) Revenue Market Share by Type (2021-2032)
5 Demerol (Meperidine) Market by Application
  1. 5.1 Demerol (Meperidine) Application Introduction
  2. 5.1.1 Diarrhea Treatment
  3. 5.1.2 Cough Treatment
  4. 5.1.3 Anesthesia
  5. 5.2 Global Demerol (Meperidine) Sales by Application
  6. 5.2.1 Global Demerol (Meperidine) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Demerol (Meperidine) Sales by Application (2021-2032)
  8. 5.2.3 Global Demerol (Meperidine) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Demerol (Meperidine) Revenue by Application
  10. 5.3.1 Global Demerol (Meperidine) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Demerol (Meperidine) Revenue by Application (2021-2032)
  12. 5.3.3 Global Demerol (Meperidine) Revenue Market Share by Application (2021-2032)
6 Global Demerol (Meperidine) Sales by Region
  1. 6.1 Global Demerol (Meperidine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Demerol (Meperidine) Sales by Region (2021-2032)
  3. 6.2.1 Global Demerol (Meperidine) Sales by Region (2021-2026)
  4. 6.2.2 Global Demerol (Meperidine) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Demerol (Meperidine) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Demerol (Meperidine) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Demerol (Meperidine) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Demerol (Meperidine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Demerol (Meperidine) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Demerol (Meperidine) Revenue by Region
  1. 7.1 Global Demerol (Meperidine) Revenue by Region
  2. 7.1.1 Global Demerol (Meperidine) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Demerol (Meperidine) Revenue by Region (2021-2026)
  4. 7.1.3 Global Demerol (Meperidine) Revenue by Region (2027-2032)
  5. 7.1.4 Global Demerol (Meperidine) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Demerol (Meperidine) Revenue (2021-2032)
  8. 7.2.2 North America Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Demerol (Meperidine) Revenue (2021-2032)
  11. 7.3.2 Europe Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Demerol (Meperidine) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Demerol (Meperidine) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Demerol (Meperidine) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceuticals
  2. 8.1.1 Sun Pharmaceuticals Company Information
  3. 8.1.2 Sun Pharmaceuticals Business Overview
  4. 8.1.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceuticals Demerol (Meperidine) Product Portfolio
  6. 8.1.5 Sun Pharmaceuticals Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Demerol (Meperidine) Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Demerol (Meperidine) Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Demerol (Meperidine) Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 Mallinckrodt Pharmaceuticals
  26. 8.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 8.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 8.5.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Portfolio
  30. 8.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 8.6 Janssen
  32. 8.6.1 Janssen Company Information
  33. 8.6.2 Janssen Business Overview
  34. 8.6.3 Janssen Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Janssen Demerol (Meperidine) Product Portfolio
  36. 8.6.5 Janssen Recent Developments
  37. 8.7 Endo Pharmaceuticals
  38. 8.7.1 Endo Pharmaceuticals Company Information
  39. 8.7.2 Endo Pharmaceuticals Business Overview
  40. 8.7.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Endo Pharmaceuticals Demerol (Meperidine) Product Portfolio
  42. 8.7.5 Endo Pharmaceuticals Recent Developments
  43. 8.8 Egalet
  44. 8.8.1 Egalet Company Information
  45. 8.8.2 Egalet Business Overview
  46. 8.8.3 Egalet Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Egalet Demerol (Meperidine) Product Portfolio
  48. 8.8.5 Egalet Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Demerol (Meperidine) Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 Actavis
  56. 8.10.1 Actavis Company Information
  57. 8.10.2 Actavis Business Overview
  58. 8.10.3 Actavis Demerol (Meperidine) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Actavis Demerol (Meperidine) Product Portfolio
  60. 8.10.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Demerol (Meperidine) Value Chain Analysis
  2. 9.1.1 Demerol (Meperidine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Demerol (Meperidine) Production Mode & Process
  6. 9.2 Demerol (Meperidine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Demerol (Meperidine) Distributors
  9. 9.2.3 Demerol (Meperidine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst